TY - JOUR
T1 - Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency
AU - Li, Juan
AU - Lei, Wei-Te
AU - Zhang, Peng
AU - Rapaport, Franck
AU - Seeleuthner, Yoann
AU - Lyu, Bingnan
AU - Asano, Takaki
AU - Rosain, Jérémie
AU - Hammadi, Boualem
AU - Zhang, Yu
AU - Pelham, Simon J
AU - Spaan, András N
AU - Migaud, Mélanie
AU - Hum, David
AU - Bigio, Benedetta
AU - Chrabieh, Maya
AU - Béziat, Vivien
AU - Bustamante, Jacinta
AU - Zhang, Shen-Ying
AU - Jouanguy, Emmanuelle
AU - Boisson-Dupuis, Stephanie
AU - El Baghdadi, Jamila
AU - Aimanianda, Vishukumar
AU - Thoma, Katharina
AU - Fliegauf, Manfred
AU - Grimbacher, Bodo
AU - Korganow, Anne-Sophie
AU - Saunders, Carol
AU - Rao, V Koneti
AU - Uzel, Gulbu
AU - Freeman, Alexandra F
AU - Holland, Steven M
AU - Su, Helen C
AU - Cunningham-Rundles, Charlotte
AU - Fieschi, Claire
AU - Abel, Laurent
AU - Puel, Anne
AU - Cobat, Aurélie
AU - Casanova, Jean-Laurent
AU - Zhang, Qian
AU - Boisson, Bertrand
N1 - Publisher Copyright:
© 2021 Li et al.
PY - 2021/11/1
Y1 - 2021/11/1
N2 - Autosomal dominant (AD) NFKB1 deficiency is thought to be the most common genetic etiology of common variable immunodeficiency (CVID). However, the causal link between NFKB1 variants and CVID has not been demonstrated experimentally and genetically, as there has been insufficient biochemical characterization and enrichment analysis. We show that the cotransfection of NFKB1-deficient HEK293T cells (lacking both p105 and its cleaved form p50) with a κB reporter, NFKB1/p105, and a homodimerization-defective RELA/p65 mutant results in p50:p65 heterodimer–dependent and p65:p65 homodimer–independent transcriptional activation. We found that 59 of the 90 variants in patients with CVID or related conditions were loss of function or hypomorphic. By contrast, 258 of 260 variants in the general population or patients with unrelated conditions were neutral. None of the deleterious variants displayed negative dominance. The enrichment in deleterious NFKB1 variants of patients with CVID was selective and highly significant (P = 2.78 × 10−15). NFKB1 variants disrupting NFKB1/p50 transcriptional activity thus underlie AD CVID by haploinsufficiency, whereas neutral variants in this assay should not be considered causal.
AB - Autosomal dominant (AD) NFKB1 deficiency is thought to be the most common genetic etiology of common variable immunodeficiency (CVID). However, the causal link between NFKB1 variants and CVID has not been demonstrated experimentally and genetically, as there has been insufficient biochemical characterization and enrichment analysis. We show that the cotransfection of NFKB1-deficient HEK293T cells (lacking both p105 and its cleaved form p50) with a κB reporter, NFKB1/p105, and a homodimerization-defective RELA/p65 mutant results in p50:p65 heterodimer–dependent and p65:p65 homodimer–independent transcriptional activation. We found that 59 of the 90 variants in patients with CVID or related conditions were loss of function or hypomorphic. By contrast, 258 of 260 variants in the general population or patients with unrelated conditions were neutral. None of the deleterious variants displayed negative dominance. The enrichment in deleterious NFKB1 variants of patients with CVID was selective and highly significant (P = 2.78 × 10−15). NFKB1 variants disrupting NFKB1/p50 transcriptional activity thus underlie AD CVID by haploinsufficiency, whereas neutral variants in this assay should not be considered causal.
KW - Animals
KW - COS Cells
KW - Cell Line
KW - Chlorocebus aethiops
KW - Common Variable Immunodeficiency/genetics
KW - HEK293 Cells
KW - Haploinsufficiency/genetics
KW - Humans
KW - NF-kappa B p50 Subunit/genetics
KW - NF-kappa B/genetics
KW - Phenotype
KW - Transcriptional Activation/genetics
UR - http://www.scopus.com/inward/record.url?scp=85116592517&partnerID=8YFLogxK
U2 - 10.1084/jem.20210566
DO - 10.1084/jem.20210566
M3 - Article
C2 - 34473196
SN - 0022-1007
VL - 218
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 11
M1 - e20210566
ER -